{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:23:15Z","timestamp":1782375795201,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ophthalmic Knowledge","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cycle for Survival"},{"name":"Ludwig Collaborative and Swim Across America Laboratory"},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ophtha.2019.09.018","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:12:50Z","timestamp":1569323570000},"page":"240-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition"],"prefix":"10.1016","volume":"127","author":[{"given":"Jasmine H.","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0118-6391","authenticated-orcid":false,"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-2672","authenticated-orcid":false,"given":"Michael","family":"Engelbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Grossniklaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baker","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Codrin E.","family":"Iacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-3930","authenticated-orcid":false,"given":"Korey","family":"Jaben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Kurli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Postow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedd D.","family":"Wolchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill R.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2019.09.018_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000658-199008000-00010","article-title":"Late recurrence of malignant melanoma. Analysis of 168 patients","volume":"212","author":"Crowley","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.ophtha.2019.09.018_bib2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","article-title":"Survey of 520 eyes\u00a0with uveal metastases","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.09.018_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000080948","article-title":"Systemic melanoma metastatic to the retina and vitreous","volume":"218","author":"Zografos","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2019.09.018_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0161-6420(98)94011-8","article-title":"Cutaneous melanoma metastatic to the vitreous cavity","volume":"105","author":"G\u00fcnd\u00fcz","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.09.018_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2019.09.018_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000296","article-title":"Ocular and orbital side-effects of checkpoint inhibitors: a review article","volume":"28","author":"Antoun","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ophtha.2019.09.018_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s12885-018-4470-y","article-title":"Unmasking of intracranial metastatic melanoma during ipilimumab\/nivolumab therapy: case report and literature review","volume":"18","author":"McDonald","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ophtha.2019.09.018_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1200\/EDBK_200643","article-title":"Patterns of response and progression to immunotherapy","volume":"38","author":"Borcoman","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ophtha.2019.09.018_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/CMR.0000000000000443","article-title":"Immune privilege: failure of immunotherapy in controlling metastatic cutaneous melanoma to the eye","volume":"28","author":"Sia","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ophtha.2019.09.018_bib10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/2326-6066.CIR-18-0067","article-title":"Improved risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: results from a national cohort","volume":"6","author":"Iorgulescu","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ophtha.2019.09.018_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2019.09.018_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ophtha.2019.09.018_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/CMR.0000000000000591","article-title":"Eye immune privilege? Nivolumab plus ipilimumab: successful treatment in a patient with cutaneous melanoma and ocular metastases","volume":"29","author":"Fernandez-Diaz","year":"2019","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ophtha.2019.09.018_bib14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2019.09.018_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ophtha.2019.09.018_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.09.018_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaophthalmol.2017.1810","article-title":"Intravitreal melphalan for treatment of primary vitreoretinal lymphoma: a new indication for an old drug","volume":"135","author":"Shields","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.09.018_bib18","article-title":"Intravitreal melphalan for treatment of vitreous seeding from choroidal melanoma","author":"Masoomian","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ophtha.2019.09.018_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jso.23558","article-title":"Isolated limb perfusion with melphalan for melanoma","volume":"109","author":"Nieweg","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ophtha.2019.09.018_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019320858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019320858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:20Z","timestamp":1758982040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019320858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0161642019320858"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.018","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}